How This Age-Old Battle That Could Further Rattle Eli Lilly Stock

FDA approves a new Alzheimer's drug from Eli Lilly

Eli Lilly CEO: We're beginning a new phase of growth

Eli Lilly CEO: We know there's high demand for weight-loss drugs and we're ready to meet it

Jim Cramer: Eli Lilly stock represents real value

Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance

Eli Lilly stock soars following data suggesting its Alzheimer's drug can slow illness